ALPS Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-51,899
| Closed | -$696K | – | 992 |
|
|
2021
Q3 | $696K | Sell |
51,899
-3,518
| -6% | -$47.2K | 0.01% | 448 |
|
|
2021
Q2 | $1.22M | Buy |
+55,417
| New | +$1.22M | 0.01% | 383 |
|
|
2020
Q4 | – | Sell |
-48,478
| Closed | -$560K | – | 886 |
|
|
2020
Q3 | $560K | Sell |
48,478
-3,002
| -6% | -$34.7K | 0.01% | 410 |
|
|
2020
Q2 | $1.25M | Sell |
51,480
-16,844
| -25% | -$409K | 0.02% | 278 |
|
|
2020
Q1 | $753K | Sell |
68,324
-7,368
| -10% | -$81.2K | 0.01% | 343 |
|
|
2019
Q4 | $2M | Buy |
75,692
+840
| +1% | +$22.2K | 0.02% | 226 |
|
|
2019
Q3 | $1.71M | Sell |
74,852
-3,560
| -5% | -$81.1K | 0.01% | 229 |
|
|
2019
Q2 | $2.4M | Sell |
78,412
-11,404
| -13% | -$350K | 0.02% | 210 |
|
|
2019
Q1 | $1.49M | Buy |
89,816
+3,885
| +5% | +$64.5K | 0.01% | 263 |
|
|
2018
Q4 | $1.65M | Buy |
85,931
+26,817
| +45% | +$514K | 0.01% | 240 |
|
|
2018
Q3 | $3.09M | Buy |
59,114
+11,656
| +25% | +$609K | 0.02% | 201 |
|
|
2018
Q2 | $2.06M | Buy |
47,458
+9,307
| +24% | +$405K | 0.01% | 227 |
|
|
2018
Q1 | $1.41M | Buy |
38,151
+6,742
| +21% | +$250K | 0.01% | 254 |
|
|
2017
Q4 | $623K | Buy |
31,409
+3,643
| +13% | +$72.3K | ﹤0.01% | 371 |
|
|
2017
Q3 | $691K | Buy |
27,766
+2,317
| +9% | +$57.7K | ﹤0.01% | 310 |
|
|
2017
Q2 | $444K | Buy |
+25,449
| New | +$444K | ﹤0.01% | 620 |
|